Deep longitudinal phenotyping of a single individual enables host–microbiome metabolic modeling over 3.6 years

This study examines a single subject (LS) experiencing severe episodic colonic inflammation and associated gut microbiome dysbiosis. Metagenomic sequencing of LS's stool samples at 51 time points over 3.6 years provided a time series of gut microbial species' relative abundances, from which we generated time-point specific microbiome models. Flux balance analysis was used to predict metabolic phenotypes across the time series. The microbial abundances and predicted fluxes were compared with clinical inflammation biomarkers [serum C-reactive protein (CRP); stool lactoferrin, calprotectin, lysozyme, and secretory immunoglobulin A]. Each of these 51 microbiome models were integrated with a time-point specific male whole-body metabolic model personalized based on LS's weight, blood glucose, and cholesterol. A healthy average (HeAve) community model from 34 individuals provided a reference. Our models predicted methane overproduction from high Methanobrevibacter smithii levels, coinciding with peak CRP and calprotectin. We found that Escherichia coli plays a central role in shaping the predicted metabolome and may promote inflammation through trimethylamine N-oxide and formaldehyde production, out-competing Desulfovibrio piger and Akkermansia muciniphila via active methyl and sulfur cycles. At a later time point, LS experienced a major shift in gut Proteobacteria ecology: E. coli, over-abundant at 675 × HeAve, dropped nearly 80-fold in one month, while Morganella morganii rose by nearly eight times, which coincided with a spike in LS's lactoferrin and lysozyme, a rise in species including Klebsiella pneumoniae and Faecalibacterium prausnitzii, a change in predicted metabolic profile, and increased alpha diversity. We also noted a correlation between postulated inflammation periods and predicted lithocholic acid levels. This work extends two previous studies of 7 and 27 of these time points. Our analysis demonstrates the value of pairing multi-omics time-series data with systems biology approaches in an n-of-1 design, resolving how microbiome composition dynamics shape host–microbiome metabolism and inflammation.

Authors

Institutions

Publication Details

Journal
Gut Microbes
Published
2026-11-19
DOI
https://doi.org/10.1080/19490976.2026.2757368
Primary Topic
Gut microbiota and health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Deep longitudinal phenotyping of a single individual enables host–microbiome metabolic modeling over 3.6 years

Rob D. Knight, Bernhard Ørn Palsson, Larry L. Smarr, Ines Thiele et al.
Gut Microbes
Gut microbiota and health
article

Deep longitudinal phenotyping of a single individual enables host–microbiome metabolic modeling over 3.6 years

Rob D. Knight, Bernhard Ørn Palsson, Larry L. Smarr, Ines Thiele, Xin Fang, Filippo Martinelli, Anna Sheehy
article en

Abstract

This study examines a single subject (LS) experiencing severe episodic colonic inflammation and associated gut microbiome dysbiosis. Metagenomic sequencing of LS's stool samples at 51 time points over 3.6 years provided a time series of gut microbial species' relative abundances, from which we generated time-point specific microbiome models. Flux balance analysis was used to predict metabolic phenotypes across the time series. The microbial abundances and predicted fluxes were compared with clinical inflammation biomarkers [serum C-reactive protein (CRP); stool lactoferrin, calprotectin, lysozyme, and secretory immunoglobulin A]. Each of these 51 microbiome models were integrated with a time-point specific male whole-body metabolic model personalized based on LS's weight, blood glucose, and cholesterol. A healthy average (HeAve) community model from 34 individuals provided a reference. Our models predicted methane overproduction from high Methanobrevibacter smithii levels, coinciding with peak CRP and calprotectin. We found that Escherichia coli plays a central role in shaping the predicted metabolome and may promote inflammation through trimethylamine N-oxide and formaldehyde production, out-competing Desulfovibrio piger and Akkermansia muciniphila via active methyl and sulfur cycles. At a later time point, LS experienced a major shift in gut Proteobacteria ecology: E. coli, over-abundant at 675 × HeAve, dropped nearly 80-fold in one month, while Morganella morganii rose by nearly eight times, which coincided with a spike in LS's lactoferrin and lysozyme, a rise in species including Klebsiella pneumoniae and Faecalibacterium prausnitzii, a change in predicted metabolic profile, and increased alpha diversity. We also noted a correlation between postulated inflammation periods and predicted lithocholic acid levels. This work extends two previous studies of 7 and 27 of these time points. Our analysis demonstrates the value of pairing multi-omics time-series data with systems biology approaches in an n-of-1 design, resolving how microbiome composition dynamics shape host–microbiome metabolism and inflammation.

Gut MicrobesVol. 18(1)
Ollscoil na Gaillimhe – University of Galway (IE), Hong Kong University of Science and Technology (HK), University College Cork (IE), Novo Nordisk Foundation (DK), University of California San Diego (US), Bristol-Myers Squibb (United States) (US), APC Microbiome Institute (IE), Technical University of Denmark (DK)
Gut microbiota and health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon